🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a Phase 1, first-in-human, open-label, dose-escalation and co...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2022-06-21
Trial ID
NCT05773937
Treatments Being Tested
This study is a multi-center, open-label, dose-escalation and dose-optimize...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-15
Trial ID
NCT07615660
Treatments Being Tested
This study is a Phase 1/2, first-in-human, open-label, dose-escalation and ...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2022-06-11
Trial ID
NCT05216965
Treatments Being Tested
This study is a Phase Ib/ll, open-label, multicenter study designed to eval...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2025-04
Trial ID
NCT06947226
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
Assess the safety and efficacy of 9MW2821 in patients with high-risk non-mu...
Status
Recruiting
Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Start Date
2024-04-22
Trial ID
NCT06551233
Treatments Being Tested
The NECTAR study is a multicenter, open-label, randomized phase II clinical...
Status
Not Yet Recruiting
Location
Peking University Third Hospital
Start Date
2026-02
Trial ID
NCT07412171
Treatments Being Tested
To evaluate the safety, tolerability, and preliminary efficacy of 9MW2821 i...
Status
Not Yet Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2025-04-15
Trial ID
NCT06926998
Treatments Being Tested
This study will compare the efficacy of 9MW2821+toripalimab versus 9MW2821 ...
Status
Recruiting
Location
Hunan Tumor Hospital
Start Date
2025-01-17
Trial ID
NCT06823427
Treatments Being Tested
This study is a Phase 2, open-label,multicenter study designed to evaluate ...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-07-26
Trial ID
NCT06492005
Treatments Being Tested